Staphylococcus aureus meningitis: A broad-based epidemiologic study

Medicine (United States)

Volumn 66, Issue 2, 1987, Pages 148-156

  Schlesinger, Larry S ^a   Ross, Stephen C ^a   Schaberg, Dennis R ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT;

BLOOD AND HEMOPOIETIC SYSTEM; CENTRAL NERVOUS SYSTEM; CEREBROSPINAL FLUID; CLINICAL ARTICLE; DIAGNOSIS; DISSEMINATED INTRAVASCULAR CLOTTING; EPIDEMIOLOGY; HUMAN; MENINGITIS; MORBIDITY; MORTALITY; NERVOUS SYSTEM; PRIORITY JOURNAL; REVIEW; STAPHYLOCOCCUS AUREUS; THERAPY;

ACUTE DISEASE; ADULT; AGE FACTORS; CHILD; HUMAN; MENINGITIS; MICHIGAN; PROGNOSIS; RISK; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0023265381     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/00005792-198703000-00006     Document Type: Article

References (59)

1. Baker CJ. Nosocomial septicemia and meningitis in neonates. Am J Med 70: 698-701, 1981.
2. Bayer AS, Lam K. Efficacy of vancomycin plus rifampin in experimental aortic valve endocarditis due to methicillin-resistant Staphylococcus aureus: In vitro-in vivo correlations. J Infect Dis 151: 157-165, 1985.
3. Bayer AS, Morrison JO. Disparity between timed-kill and checkerboard methods for determination of in vitro bactericidal interactions of vancomycin plus rifampin versus methicillin-susceptible and resistant Staphylococcus aureus. Antimicrob Agents Chemother 26: 220-223, 1984.
4. Bennet R, Eriksson M, Zetterstrom R. Increasing incidence of neonatal septicemia: Causative organism and predisposing risk factors. Acta Paediatr Scand 70: 207-210, 1981.
5. Bohr V, Hansen B, Jessen O, Johnsen N, Kjersem H, Kristensen HS, Nyboe J, Rasmussen N. Eight hundred and seventy-five cases of bacterial meningitis. Part I of a three-part series: Clinical data, prognosis, and the role of specialised hospital departments. J Infect 7: 21-30, 1983.
6. Bohr V, Rasmussen N, Hansen B, Gade A, Kjersem H, Johnsen N, Paulson O. Pneumococcal meningitis: an evaluation of prognostic factors in 164 cases based on mortality and on a study of lasting sequelae. J Infect 10: 143-157, 1985.
7. Carson MJ, Koch R. Management of bacterial meningitis in children. Pediatr Clin North Am 3: 377-398, 1956.
8. Cluff LE, Reynolds RC. Management of staphylococcal infections. Am J Med 39: 812-825, 1965.
9. Cluff LE, Reynolds RC, Page DL, Breckenridge JL. Staphylococcal bacteremia and altered host resistance. Ann Intern Med 69: 859-873, 1968.
10. Cunha BA, Ristuccia AM. Clinical usefulness of vancomycin. Clin Pharm 2: 417-424, 1983.
11. Demuth PJ, Gerding DN, Crossley K. Staphylococcus aureus bacte-riuria. Arch Intern Med 139: 78-80, 1979.
12. Dodge PR, Davis H, Feigin RD, Holmes SJ, Kaplan SL, Jubelirer DP, Stechenberg DW, Hirsh SK. Prospective evaluation of hearing impairment as a sequela of acute bacterial meningitis. N Engl J Med 311: 869-874, 1984.
13. Eigler JOC, Wellman WE, Rooke ED, Keith HM, Svien HJ. Bacterial meningitis. I. General review. Mayo Clin Proc 36: 357-365, 1961.
14. Everitt ED, Strausbaugh LJ. Antimicrobial agents and the central nervous system. Neurosurgery 6: 691-714, 1980.
15. Finland M, Barnes MW. Acute bacterial meningitis at Boston City Hospital during 12 selected years, 1935-1972. J Infect Dis 136: 400-415, 1977.
16. Fong IW, Ranalli P. Staphylococcus aureus meningitis. Q J Med 210: 289-299, 1984.
17. Forbes JA. Purulent meningitis: Principles and results of revised standardized treatment in 281 cases. Australasian Ann Med 11: 92-101, 1962.
18. Fraser DW, Henke CE, Feldman RA. Changing patterns of bacterial meningitis in Olmsted County, Minnesota, 1935-1970. J Infect Dis 128: 300-307, 1973.
19. Geiseler PJ, Nelson KE, Levin S, Reddi KT, Moses VK. Community acquired purulent meningitis: A review of 1, 316 cases during the antibiotic era, 1954-1976. Rev Infect Dis 2: 725-745, 1980.
20. Gold R. Bacterial meningitis-1982. Am J Med; 98-101, 1983.
21. Gomberl ME, Landesman SH, Corrado ML, Stein SC, McWin ET, Cummings M. Vancomycin and rifampin therapy for Staphylococcus epidermidi* meningitis associated with CSF shunts. J Neurosurg 55: 633-36, 1981.
22. Gordon JJ, Harter DH, Phair JP. Meningitis due to Staphylococcus aureus. Am J Med 78: 965-970, 1985.
23. Gump DW. Vancomycin for treatment of bacterial meningitis. Rev Infect Dis 3 (suppl): S289-S292, 1981.
24. Hawley B, Gump DW. Vancomycin therapy of bacterial meningitis. Am J Dis Child 126: 261-264, 1973.
25. Hyland HH. Modern experience in bacterial meningitis. Canad Med Assoc J 81: 883-885, 1959.
26. Kane JG, Parker RH, Jordon GW, Hoeprich PD. Nafcillin concentration in cerebrospinal fluid during treatment of staphylococcal infections. Ann Intern Med 87: 309-311, 1977.
27. Klein JO, Marcy SM. Bacterial sepsis and meningitis. In: Remington J, Klein J, eds. Infectious diseases of the fetus and newborn infants. Philadelphia: W.B. Saunders Company, pp. 679-725, 1983.
28. Lee BK, Crossley K, Gerding DN. The association between Staphylococcus aureus bacteremia and bacteriuria. Am J Med 65: 303-306, 1978.
29. Levitz RE, Quintiliani R. Trimethoprim-sulfamethoxazole for bacterial meningitis. Ann Inter Med 100: 881-890, 1984.
30. McGee ZA, Kaiser AB. Acute meningitis. In: Mandeli GL, Douglas RG Jr, Bennett JE, eds. Principles and practice of infectious diseases. New York: John Wiley and Sons, Inc., pp. 560-573, 1985.
31. Mulcare RJ, Harter DH. Changing patterns of staphylococcal meningitis. Arch Neurol 7: 114-120, 1962.
32. Murray HW, Tuazon CU, Sheagren JN. Staphylococcal septicemia and disseminated intravascular coagulation. Arch Intern Med 137: 844-847, 1977.
33. Musher DM, McKenzie SO. Infections due to Staphylococcus aureus. Medicine 56: 383-409, 1977.
34. Nolan CM, Beaty HN. Staphylococcus aureus bacteremia. Am J Med 60: 495-500, 1976.
35. O'Connor DT, Weisman MH, Fierer J. Activation of the alternative complement pathway in Staphylococcus aureus infective endocarditis and its relationship to thrombocytopenia, coagulation abnormalities, and acute glomerulonephritis. Clin Exp Immunol 34: 179-87, 1978.
36. Quaade F, Kristensen KP. Purulent meningitis. Acta Med Scand 171: 543-549, 1962.
37. Redfield D, Underman A, Norman D, Overturf GD. Cerebrospinal fluid penetration of vancomycin in bacterial meningitis. In: Nelson JD, Grassi C, eds. Current chemotherapy and infectious disease. Proceedings of the I Ith International Congress of Chemotherapy and the 19th Interscience Conference on Antimicrobial Agents and Chemotherapy. Vol. I. Washington, D.C.: American Society for Microbiology. pp. 638-640, 1980.
38. Roberts FJ, Smith JA, Wagner KR. Staphylococcus aureus meningitis: 26 years' experience at Vancouver General Hospital. Can Med Assoc J 128: 1418-1420, 1983.
39. Ruiz DE, Warner JF. Nafcillin treatment of Staphylococcus aureus meningitis. Antimicrob Agents Chemother 9: 554-555, 1976.
40. Sell SH. Long term sequelae of bacterial meningitis in children. Pediatr Infect Dis 2: 90-93, 1983.
41. Sheagren JN. Staphylococcus aureus. The persistent pathogen. N Engl J Med 310: 1368-1373, 1984.
42. Shinefield HR. Staphylococcal infections. In: Remington J, Klein J, eds. Infectious diseases of the fetus and newborn infant. Philadelphia: W.B. Saunders Company, pp. 882-916, 1983.
43. Sorrell TC, Packham DR, Shanker S, Foldes M, Munro R. Vancomycin therapy in methicillin-resistant Staphylococcus aureus. Ann Intern Med 97: 344-350, 1982.
44. Strausbaugh LJ, Murray TW, Sande MA. Comparative penetration of six antibiotics into the cerebrospinal fluid of rabbits with experimental staphylococcal meningitis. J Antimicrob Chemother 6: 363-371, 1980.
45. Studdert TC. Staphylococcal spinal meningitis. Br Med J 1: 1457-1459, 1958.
46. Swartz MN, Dodge PR. Bacterial meningitis-a review of selected aspects. N Engl J Med 272: 725-731, 1965.
47. Tamer MA, Bray JD. Trimethoprim-sulfamethoxazole treatment of multiantibiotic resistant staphylococcal endocarditis and meningitis. Clin Pediatr 21: 125-126, 1981.
48. Tuazon CU, Lin MY, Sheagren JN. In vitro activity of rifampin alone and in combination with nafcillin and vancomycin against pathogenic strains of Staphylococcus aureus. Antimicrob Agents Chemother 13: 759-761, 1978.
49. Tuazon CU, Sheagren JN, Quie PG. Variability in the degree of a opsonization and phagocytosis of strains of Staphylococcus aureus isolated from patients with disseminated intravascular coagulation. J Lab Clin Med 98: 949-955, 1981.
50. Vichyanond P, Olson L. Staphylococcal CNS infections treated with vancomycin and rifampin. Arch Neurol 41: 637-639, 1984.
51. Waldvogel FA. Staphylococcus aureus (including toxic shock syndrome). In: Mandeli GL, Douglas RG, Jr., Bennett JE, eds. Principles and practices of infectious diseases. New York: John Wiley and Sons, Inc., pp. 1097-1116, 1985.
52. Watanakunakorn C. Treatment of infections due to methicillin-resistant Staphylococcus aureus. Ann Intern Med 97: 376-378, 1982.
53. Watanakunakorn C, Guerriero JC. Interaction between vancomycin and rifampin against Staphylococcus aureus. Antimicrob Agents Chemother 19: 1089-1091, 1981.
54. Weinstein MP, LaForce FM, Mangi RJ, Quintiliani R. Non-pneu-mococcal gram positive coccal meningitis related to neurosurgery. J Neurosurg 47: 236-240, 1977.
55. Wellman WE, Senft RA. Bacterial meningitis. III. Infections caused by Staphylococcus aureus. Mayo Clin Proc 39: 263-269, 1964.
56. Wilson R, Hamburger M. Fifteen years' experience with staphylococcus septicemia in a large city hospital. Am J Med 22: 437-455, 1957.
57. Yogev R, Davis AT. Neurosurgical shunt infections. Child's Brain 6: 74-81, 1980.
58. Yogev R, Schultz WE, Rosenman SB. Penetrance of nafcillin into human ventricular fluid: correlation with ventricular pleocytosis and glucose levels. Antimicrob Agents Chemother 19: 545-548, 1981.
59. Zinner SH, Lagast H, Klastersky J. Anti-staphylococcal activity of rifampin with other antibiotics. J Infect Dis 144: 365-371, 1981.